Intrinsic value of Senseonics Holdings - SENS

Previous Close

$2.96

  Intrinsic Value

$0.01

stock screener

  Rating & Target

str. sell

-100%

Previous close

$2.96

 
Intrinsic value

$0.01

 
Up/down potential

-100%

 
Rating

str. sell

We calculate the intrinsic value of SENS stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.5

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  60.00
  54.50
  49.55
  45.10
  41.09
  37.48
  34.23
  31.31
  28.68
  26.31
  24.18
  22.26
  20.53
  18.98
  17.58
  16.32
  15.19
  14.17
  13.26
  12.43
  11.69
  11.02
  10.42
  9.87
  9.39
  8.95
  8.55
  8.20
  7.88
  7.59
Revenue, $m
  10
  16
  24
  34
  48
  66
  89
  117
  150
  190
  236
  288
  348
  414
  486
  566
  652
  744
  842
  947
  1,058
  1,174
  1,297
  1,425
  1,559
  1,698
  1,843
  1,994
  2,152
  2,315
Variable operating expenses, $m
  263
  407
  609
  883
  1,246
  1,713
  2,299
  3,019
  3,885
  4,907
  6,093
  7,449
  8,979
  10,683
  12,561
  14,612
  16,831
  19,217
  21,764
  24,469
  27,329
  30,340
  33,500
  36,808
  40,263
  43,866
  47,619
  51,522
  55,582
  59,801
Fixed operating expenses, $m
  36
  37
  37
  38
  39
  40
  41
  42
  43
  44
  44
  45
  46
  47
  49
  50
  51
  52
  53
  54
  55
  56
  58
  59
  60
  62
  63
  64
  66
  67
Total operating expenses, $m
  299
  444
  646
  921
  1,285
  1,753
  2,340
  3,061
  3,928
  4,951
  6,137
  7,494
  9,025
  10,730
  12,610
  14,662
  16,882
  19,269
  21,817
  24,523
  27,384
  30,396
  33,558
  36,867
  40,323
  43,928
  47,682
  51,586
  55,648
  59,868
Operating income, $m
  -289
  -428
  -622
  -887
  -1,237
  -1,686
  -2,251
  -2,944
  -3,777
  -4,760
  -5,901
  -7,206
  -8,678
  -10,317
  -12,123
  -14,096
  -16,230
  -18,525
  -20,974
  -23,576
  -26,326
  -29,222
  -32,261
  -35,442
  -38,765
  -42,230
  -45,838
  -49,592
  -53,496
  -57,553
EBITDA, $m
  -289
  -427
  -622
  -886
  -1,235
  -1,685
  -2,249
  -2,941
  -3,773
  -4,755
  -5,895
  -7,199
  -8,668
  -10,306
  -12,111
  -14,081
  -16,213
  -18,505
  -20,952
  -23,551
  -26,298
  -29,191
  -32,227
  -35,405
  -38,724
  -42,185
  -45,790
  -49,540
  -53,439
  -57,492
Interest expense (income), $m
  1
  4
  4
  7
  11
  16
  22
  31
  42
  55
  71
  89
  111
  136
  164
  195
  229
  267
  307
  351
  397
  447
  499
  554
  612
  672
  735
  801
  870
  941
  1,015
Earnings before tax, $m
  -293
  -432
  -629
  -898
  -1,252
  -1,709
  -2,282
  -2,985
  -3,832
  -4,831
  -5,991
  -7,317
  -8,813
  -10,480
  -12,318
  -14,325
  -16,497
  -18,832
  -21,325
  -23,973
  -26,773
  -29,721
  -32,815
  -36,054
  -39,437
  -42,965
  -46,639
  -50,462
  -54,437
  -58,568
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  -293
  -432
  -629
  -898
  -1,252
  -1,709
  -2,282
  -2,985
  -3,832
  -4,831
  -5,991
  -7,317
  -8,813
  -10,480
  -12,318
  -14,325
  -16,497
  -18,832
  -21,325
  -23,973
  -26,773
  -29,721
  -32,815
  -36,054
  -39,437
  -42,965
  -46,639
  -50,462
  -54,437
  -58,568

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  38
  59
  89
  129
  182
  250
  336
  441
  567
  717
  890
  1,088
  1,312
  1,561
  1,835
  2,134
  2,459
  2,807
  3,179
  3,574
  3,992
  4,432
  4,894
  5,377
  5,882
  6,408
  6,956
  7,526
  8,119
  8,735
Adjusted assets (=assets-cash), $m
  38
  59
  89
  129
  182
  250
  336
  441
  567
  717
  890
  1,088
  1,312
  1,561
  1,835
  2,134
  2,459
  2,807
  3,179
  3,574
  3,992
  4,432
  4,894
  5,377
  5,882
  6,408
  6,956
  7,526
  8,119
  8,735
Revenue / Adjusted assets
  0.263
  0.271
  0.270
  0.264
  0.264
  0.264
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
  0.265
Average production assets, $m
  1
  2
  3
  5
  6
  9
  12
  15
  20
  25
  31
  38
  46
  55
  64
  75
  86
  98
  111
  125
  140
  155
  171
  188
  206
  224
  243
  263
  284
  306
Working capital, $m
  -8
  -12
  -18
  -27
  -38
  -52
  -69
  -91
  -117
  -148
  -184
  -225
  -271
  -322
  -379
  -441
  -508
  -579
  -656
  -738
  -824
  -915
  -1,010
  -1,110
  -1,214
  -1,323
  -1,436
  -1,554
  -1,676
  -1,803
Total debt, $m
  31
  50
  77
  113
  161
  222
  299
  394
  507
  642
  798
  976
  1,177
  1,401
  1,648
  1,918
  2,210
  2,523
  2,858
  3,214
  3,590
  3,986
  4,401
  4,836
  5,290
  5,764
  6,257
  6,770
  7,304
  7,859
Total liabilities, $m
  35
  54
  80
  116
  164
  225
  302
  397
  511
  645
  801
  979
  1,180
  1,404
  1,651
  1,921
  2,213
  2,526
  2,861
  3,217
  3,593
  3,989
  4,404
  4,839
  5,293
  5,767
  6,260
  6,774
  7,307
  7,862
Total equity, $m
  4
  6
  9
  13
  18
  25
  34
  44
  57
  72
  89
  109
  131
  156
  183
  213
  246
  281
  318
  357
  399
  443
  489
  538
  588
  641
  696
  753
  812
  874
Total liabilities and equity, $m
  39
  60
  89
  129
  182
  250
  336
  441
  568
  717
  890
  1,088
  1,311
  1,560
  1,834
  2,134
  2,459
  2,807
  3,179
  3,574
  3,992
  4,432
  4,893
  5,377
  5,881
  6,408
  6,956
  7,527
  8,119
  8,736
Debt-to-equity ratio
  8.170
  8.460
  8.640
  8.750
  8.820
  8.870
  8.900
  8.930
  8.940
  8.960
  8.960
  8.970
  8.980
  8.980
  8.980
  8.980
  8.990
  8.990
  8.990
  8.990
  8.990
  8.990
  8.990
  8.990
  8.990
  8.990
  9.000
  9.000
  9.000
  9.000
Adjusted equity ratio
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -293
  -432
  -629
  -898
  -1,252
  -1,709
  -2,282
  -2,985
  -3,832
  -4,831
  -5,991
  -7,317
  -8,813
  -10,480
  -12,318
  -14,325
  -16,497
  -18,832
  -21,325
  -23,973
  -26,773
  -29,721
  -32,815
  -36,054
  -39,437
  -42,965
  -46,639
  -50,462
  -54,437
  -58,568
Depreciation, amort., depletion, $m
  0
  0
  1
  1
  1
  2
  2
  3
  4
  5
  6
  8
  9
  11
  13
  15
  17
  20
  22
  25
  28
  31
  34
  38
  41
  45
  49
  53
  57
  61
Funds from operations, $m
  -292
  -432
  -629
  -897
  -1,251
  -1,707
  -2,279
  -2,982
  -3,828
  -4,826
  -5,984
  -7,309
  -8,804
  -10,469
  -12,305
  -14,310
  -16,480
  -18,812
  -21,303
  -23,948
  -26,745
  -29,690
  -32,781
  -36,017
  -39,396
  -42,921
  -46,591
  -50,410
  -54,380
  -58,507
Change in working capital, $m
  -3
  -4
  -6
  -8
  -11
  -14
  -18
  -22
  -26
  -31
  -36
  -41
  -46
  -51
  -57
  -62
  -67
  -72
  -77
  -82
  -86
  -91
  -95
  -100
  -104
  -109
  -113
  -118
  -122
  -127
Cash from operations, $m
  -289
  -427
  -623
  -889
  -1,240
  -1,693
  -2,262
  -2,960
  -3,801
  -4,795
  -5,949
  -7,269
  -8,758
  -10,418
  -12,249
  -14,248
  -16,413
  -18,740
  -21,226
  -23,867
  -26,659
  -29,599
  -32,686
  -35,917
  -39,292
  -42,812
  -46,478
  -50,292
  -54,258
  -58,380
Maintenance CAPEX, $m
  0
  0
  0
  -1
  -1
  -1
  -2
  -2
  -3
  -4
  -5
  -6
  -8
  -9
  -11
  -13
  -15
  -17
  -20
  -22
  -25
  -28
  -31
  -34
  -38
  -41
  -45
  -49
  -53
  -57
New CAPEX, $m
  -1
  -1
  -1
  -1
  -2
  -2
  -3
  -4
  -4
  -5
  -6
  -7
  -8
  -9
  -10
  -10
  -11
  -12
  -13
  -14
  -15
  -15
  -16
  -17
  -18
  -18
  -19
  -20
  -21
  -22
Cash from investing activities, $m
  -1
  -1
  -1
  -2
  -3
  -3
  -5
  -6
  -7
  -9
  -11
  -13
  -16
  -18
  -21
  -23
  -26
  -29
  -33
  -36
  -40
  -43
  -47
  -51
  -56
  -59
  -64
  -69
  -74
  -79
Free cash flow, $m
  -290
  -428
  -624
  -891
  -1,243
  -1,697
  -2,266
  -2,967
  -3,809
  -4,804
  -5,960
  -7,282
  -8,773
  -10,436
  -12,269
  -14,271
  -16,439
  -18,770
  -21,259
  -23,903
  -26,698
  -29,642
  -32,733
  -35,968
  -39,347
  -42,871
  -46,542
  -50,360
  -54,331
  -58,458
Issuance/(repayment) of debt, $m
  6
  19
  27
  36
  48
  61
  77
  95
  114
  134
  156
  178
  201
  224
  247
  270
  292
  314
  335
  356
  376
  396
  415
  435
  454
  474
  493
  513
  534
  555
Issuance/(repurchase) of shares, $m
  302
  434
  632
  902
  1,258
  1,716
  2,290
  2,996
  3,844
  4,846
  6,008
  7,337
  8,836
  10,505
  12,346
  14,355
  16,529
  18,867
  21,362
  24,013
  26,815
  29,765
  32,861
  36,102
  39,488
  43,018
  46,694
  50,519
  54,496
  58,630
Cash from financing (excl. dividends), $m  
  308
  453
  659
  938
  1,306
  1,777
  2,367
  3,091
  3,958
  4,980
  6,164
  7,515
  9,037
  10,729
  12,593
  14,625
  16,821
  19,181
  21,697
  24,369
  27,191
  30,161
  33,276
  36,537
  39,942
  43,492
  47,187
  51,032
  55,030
  59,185
Total cash flow (excl. dividends), $m
  19
  25
  35
  47
  62
  80
  101
  124
  149
  176
  204
  233
  263
  293
  323
  353
  382
  411
  438
  466
  492
  518
  544
  569
  595
  620
  646
  672
  699
  726
Retained Cash Flow (-), $m
  -302
  -434
  -632
  -902
  -1,258
  -1,716
  -2,290
  -2,996
  -3,844
  -4,846
  -6,008
  -7,337
  -8,836
  -10,505
  -12,346
  -14,355
  -16,529
  -18,867
  -21,362
  -24,013
  -26,815
  -29,765
  -32,861
  -36,102
  -39,488
  -43,018
  -46,694
  -50,519
  -54,496
  -58,630
Prev. year cash balance distribution, $m
  13
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  -271
  -410
  -598
  -855
  -1,195
  -1,635
  -2,189
  -2,872
  -3,695
  -4,670
  -5,804
  -7,103
  -8,572
  -10,212
  -12,022
  -14,002
  -16,147
  -18,456
  -20,924
  -23,547
  -26,322
  -29,247
  -32,317
  -35,533
  -38,893
  -42,398
  -46,048
  -49,847
  -53,797
  -57,904
Discount rate, %
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
  -260
  -375
  -520
  -704
  -926
  -1,187
  -1,479
  -1,795
  -2,123
  -2,448
  -2,756
  -3,031
  -3,259
  -3,428
  -3,530
  -3,558
  -3,513
  -3,399
  -3,222
  -2,992
  -2,723
  -2,427
  -2,118
  -1,810
  -1,513
  -1,237
  -988
  -771
  -587
  -436
Current shareholders' claim on cash, %
  50.0
  4.1
  0.3
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0

Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company's Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user's mobile device, such as a smartphone, Apple Watch or tablet.

FINANCIAL RATIOS  of  Senseonics Holdings (SENS)

Valuation Ratios
P/E Ratio -6.3
Price to Sales 0
Price to Book -55.4
Price to Tangible Book
Price to Cash Flow -7.3
Price to Free Cash Flow -7.3
Growth Rates
Sales Growth Rate -100%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate NaN%
Cap. Spend. - 3 Yr. Gr. Rate NaN%
Financial Strength
Quick Ratio 5
Current Ratio 0
LT Debt to Equity -300%
Total Debt to Equity -380%
Interest Coverage -43
Management Effectiveness
Return On Assets -318.5%
Ret/ On Assets - 3 Yr. Avg. -506.2%
Return On Total Capital -800%
Ret/ On T. Cap. - 3 Yr. Avg. 400%
Return On Equity 586.7%
Return On Equity - 3 Yr. Avg. 395.6%
Asset Turnover 0
Profitability Ratios
Gross Margin 0%
Gross Margin - 3 Yr. Avg. 0%
EBITDA Margin 0%
EBITDA Margin - 3 Yr. Avg. 0%
Operating Margin 0%
Oper. Margin - 3 Yr. Avg. 0%
Pre-Tax Margin 0%
Pre-Tax Margin - 3 Yr. Avg. 0%
Net Profit Margin 0%
Net Profit Margin - 3 Yr. Avg. 0%
Effective Tax Rate 0%
Eff/ Tax Rate - 3 Yr. Avg. 0%
Payout Ratio 0%

SENS stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the SENS stock intrinsic value calculation we used $6.373 million for the last fiscal year's total revenue generated by Senseonics Holdings. The default revenue input number comes from 0001 income statement of Senseonics Holdings. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our SENS stock valuation model: a) initial revenue growth rate of 60% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for SENS is calculated based on our internal credit rating of Senseonics Holdings, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Senseonics Holdings.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of SENS stock the variable cost ratio is equal to 2583.3%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $35 million in the base year in the intrinsic value calculation for SENS stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 13.9% for Senseonics Holdings.

Corporate tax rate of 27% is the nominal tax rate for Senseonics Holdings. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the SENS stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for SENS are equal to 13.2%.

Life of production assets of 3.5 years is the average useful life of capital assets used in Senseonics Holdings operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for SENS is equal to -77.9%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $7.267 million for Senseonics Holdings - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 176.027 million for Senseonics Holdings is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Senseonics Holdings at the current share price and the inputted number of shares is $0.5 billion.

RELATED COMPANIES Price Int.Val. Rating
DXCM DexCom 135.75 80.46  sell
TNDM Tandem Diabete 33.12 15.38  str.sell
ABT Abbott Laborat 70.73 72.84  hold
DRIO DarioHealth 0.780 0.06  str.sell
JNJ Johnson&Johnso 144.50 176.79  buy
BDX Becton Dickins 240.04 1,279.12  str.buy

COMPANY NEWS

▶ Senseonics: 3Q Earnings Snapshot   [05:21PM  Associated Press]
▶ Sensor Receives $194,587 in New Contracts   [Oct-25-18 08:00AM  Newsfile]
▶ Why Senseonics Holdings Inc. Is Soaring Today   [Oct-23-18 10:53AM  Motley Fool]
▶ Senseonics: 2Q Earnings Snapshot   [06:29PM  Associated Press]
▶ Penny Stocks to Watch for August 2018   [Jul-31-18 01:37PM  Investopedia]
▶ 3 Best Diabetes Stocks of 2018 So Far   [Jul-03-18 06:34AM  Motley Fool]
▶ Senseonics Announces Public Offering of Common Stock   [Jun-25-18 04:11PM  Business Wire]
▶ FDA approves first implantable glucose monitor   [Jun-21-18 04:08PM  MarketWatch]
▶ 3 Top Stocks Under $5   [May-17-18 06:33AM  Motley Fool]
▶ Senseonics: 1Q Earnings Snapshot   [May-10-18 05:29PM  Associated Press]
▶ What Stocks Perform Well in the Midst of a Trade War?   [Apr-08-18 07:17AM  Motley Fool]
▶ Here's Why Senseonics Holdings Inc. Is Rising Today   [Apr-04-18 03:35PM  Motley Fool]
▶ Senseonics Announces Date for FDA Advisory Panel   [Mar-01-18 08:45AM  Business Wire]
▶ Senseonics to Participate in Upcoming Investor Conferences   [Feb-28-18 04:30PM  Business Wire]
▶ Senseonics reports 3Q loss   [05:19PM  Associated Press]
▶ Here's What Lifted Senseonics Holdings Inc. Stock   [Aug-18-17 04:37PM  Motley Fool]
▶ Senseonics reports 2Q loss   [Aug-09-17 05:43PM  Associated Press]
▶ Senseonics raises $41M from Roche, NEA for implantable glucose monitor   [May-31-17 03:47PM  American City Business Journals]
▶ Senseonics reports 1Q loss   [May-04-17 05:34PM  Associated Press]
▶ Senseonics Draws Third Tranche of Existing Loan Facility   [Mar-30-17 04:30PM  Business Wire]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.